Abstract: A system includes one or more processors configured to determine that a vehicle is attempting to enter an area designated for off-road travel. The processors are also configured to access use-restrictions stored in a database and associated with the area, the use-restrictions defining at least one vehicle constraint required for the vehicle to travel over one or more locations that are part of the area, the use restrictions defining at least one of vehicle control limiting or vehicle weight maximums. The processors are further configured to determine whether the vehicle meets the use-restrictions based on an assessment of vehicle characteristics compared to the use-restrictions and responsive to determining that the vehicle meets the restrictions, providing the vehicle with a digital access pass to the area.

Abstract: A system receives identification of an item to be loaded into a vehicle and determines dimensions of the item. The system adds the item to a total load for an identified vehicle and, based on known dimensions of available space in the identified vehicle, determines one or more candidate placement options for each of one or more items comprising the total load, within available space within the vehicle, wherein candidate placement options for each item are determined so as not to overlap with placement options for another of the one or more items within a given configuration representing placement options for all of the one or more items comprising the total load. Additionally, the system presents a visual rendering of at least one given configuration that successfully allows the total load to fit within the available space.

Abstract: A microphone assembly can include a microphone capsule having a diaphragm and a diaphragm cover, a grill for protecting the microphone capsule, and a filter material placed between the grill and the diaphragm cover. The microphone assembly can include a first air gap between the grill and the filter material to create a first interface, a second air gap between the filter material and the diaphragm cover to create a second interface, and a third air gap between the diaphragm cover and a diaphragm to create a third interface. The first interface, the second interface, and the third interface are each configured to create turbulence to assist in draining off energy from plosives and wind and reduce intensity of disturbances at the diaphragm. The filter material may include a mesh and can be supported by a frame, and the frame may be configured to fit underneath the grill.

Abstract: A microphone assembly can include a microphone capsule having a diaphragm and a diaphragm cover, a grill for protecting the microphone capsule, and a filter material placed between the grill and the diaphragm cover. The microphone assembly can include a first air gap between the grill and the filter material to create a first interface, a second air gap between the filter material and the diaphragm cover to create a second interface, and a third air gap between the diaphragm cover and a diaphragm to create a third interface. The first interface, the second interface, and the third interface are each configured to create turbulence to assist in draining off energy from plosives and wind and reduce intensity of disturbances at the diaphragm. The filter material may include a mesh and can be supported by a frame, and the frame may be configured to fit underneath the grill.

Abstract: A home testing kit used to collect a blood sample of the user and a method of blood analysis used to calculate correct mixtures of THC and CBD for each patient's desired therapeutic benefit.

Abstract: A 15 kDa selenium-containing protein (“selenoprotein”) is disclosed. The protein is shown to be differentially expressed in cancer cells, such as prostate cancer cells. There is a correlation between the presence of a polymorphism at nucleotide positions 811 and 1125 of the 15 kDa selenoprotein gene, and the presence of cancer. This polymorphism is more prevalent in the African American population. The determination of an individual's genotype may be used as an indicator of the need for dietary selenium supplementation to inhibit tumor development. Compositions including the isolated protein, specific binding agents that recognize the protein, as well as underlying nucleic acid sequences are presented, as are methods of using such compositions.

Abstract: A 15 kDa selenium-containing protein (“selenoprotein”) is disclosed. The protein is shown to be differentially expressed in cancer cells, such as prostate cancer cells. There is a correlation between the presence of a polymorphism at nucleotide positions 811 and 1125 of the 15 kDa selenoprotein gene, and the presence of cancer. This polymorphism is more prevalent in the African American population. The determination of an individual's genotype may be used as an indicator of the need for dietary selenium supplementation to inhibit tumor development. Compositions including the isolated protein, specific binding agents that recognize the protein, as well as underlying nucleic acid sequences are presented, as are methods of using such compositions.

Abstract: A 15 kDa selenium-containing protein (“selenoprotein”) is disclosed. The protein is shown to be differentially expressed in cancer cells, such as prostate cancer cells. There is a correlation between the presence of a polymorphism at nucleotide positions 811 and 1125 of the 15 kDa selenoprotein gene, and the presence of cancer. This polymorphism is more prevalent in the African American population. The determination of an individual's genotype may be used as an indicator of the need for dietary selenium supplementation to inhibit tumor development. Compositions including the isolated protein, specific binding agents that recognize the protein, as well as underlying nucleic acid sequences are presented, as are methods of using such compositions.

Abstract: A 15 kDa selenium-containing protein (“selenoprotein”) is disclosed. The protein is shown to be differentially expressed in cancer cells, such as prostate cancer cells. There is a correlation between the presence of a polymorphism at nucleotide positions 811 and 1125 of the 15 kDa selenoprotein gene, and the presence of cancer. This polymorphism is more prevalent in the African American population. The determination of an individual's genotype may be used as an indicator of the need for dietary selenium supplementation to inhibit tumor development. Compositions including the isolated protein, specific binding agents that recognize the protein, as well as underlying nucleic acid sequences are presented, as are methods of using such compositions.

Abstract: A 15 kDa selenium-containing protein (“selenoprotein”) is disclosed. The protein is shown to be differentially expressed in cancer cells, such as prostate cancer cells. There is a correlation between the presence of a polymorphism at nucleotide positions 811 and 1125 of the 15 kDa selenoprotein gene, and the presence of cancer. This polymorphism is more prevalent in the African American population. The determination of an individual's genotype may be used as an indicator of the need for dietary selenium supplementation to inhibit tumor development. Compositions including the isolated protein, specific binding agents that recognize the protein, as well as underlying nucleic acid sequences are presented, as are methods of using such compositions.